[Prevention of pulmonary thromboembolism by percutaneous implantation of REPTELA vena cava-filter].
Experience in clinical application of the new antiembolic REPTELA cava-filter is generalized. The immediate (750 patients) and late-term results (400 patients) of implantation of the filter are discussed. Thromboembolism of the pulmonary artery was encountered in the postimplantation period in 1.2% of patients with 0.2% lethality. Technical faults of implantation were the causes of antiembolic inefficacy of the cava-filter.
Savel'ev
V S
VS
Iablokov
E G
EG
Prokubovskiĭ
V I
VI
Kolodiĭ
S M
SM
Muradian
R A
RA
D004867:Equipment Design; D005374:Filtration / Q000295:instrumentation*; D006801:Humans; D011095:Polyethylenes; D019736:Prostheses and Implants; D011655:Pulmonary Embolism / Q000517:prevention & control*; D014586:USSR; D014682:Vena Cava, Inferior / Q000601:surgery*
D011095:Polyethylenes
Profilaktika tromboémbolii legochnoĭ arterii metodom chreskozhnoĭ implantatsii kava-fil'tra REPTELA.